291
Gene Therapy for Haemophilia A.
Condition(s):Hemophilia ALast Updated:March 13, 2020Recruiting
Factor VIII: 881 Clinical Trials, Page 30 of 89
Hide Studies Not Open or Pending
292
An Expanded Access Program of Emicizumab in Participants With Hemophilia A With Inhibitors
Condition(s):Hemophilia ALast Updated:March 29, 2018Approved for marketing
293
Evaluation of SCT800 in Prophylaxis Therapy on Previous Treated Patients With Severe Hemophilia A
Condition(s):Hemophilia ALast Updated:February 6, 2020Completed
294
Research Study to Look at Side Effects During Regular Injection With Factor VIII Medicine Named Turoctocog Alfa for a 8 Weeks Period
Condition(s):Congenital Bleeding Disorder; Haemophilia ALast Updated:April 17, 2020Completed
295
Adverse Event Data Collection From the EUHASS Registry on Turoctocog Alfa Pegol
Condition(s):Haemophilia ALast Updated:January 26, 2023Enrolling by invitation
296
Safety and Efficacy Extension Study of GreenGene™ F in Previously Treated Patients Diagnosed With Severe Hemophilia A
Condition(s):Hemophilia ALast Updated:January 6, 2014Unknown status
297
Evaluation of Safety Following Immune Tolerance Induction Treatment With Turoctocog Alfa in Patients With Haemophilia A Following Inhibitor Development in NN7170-4213 Trial
Condition(s):Haemophilia ALast Updated:July 7, 2020Terminated
298
A Study to Evaluate the Safety and Tolerability of Prophylactic Emicizumab in Hemophilia A Patients With Inhibitors
Condition(s):Hemophilia ALast Updated:June 11, 2021Completed
299
Factor IX as Adjunctive Therapy to Emicizumab (EMIX)
Condition(s):Hemophilia ALast Updated:November 17, 2022Recruiting
300
Females With Severe or Moderate Hemophilia A or B: A Multi-Center Study
Condition(s):Hemophilia A; Hemophilia BLast Updated:December 10, 2012Completed